Patient
SITE009-0268
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE009 (AUS) (Dr. Novak)
consented 2026-07-24
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 2
mild
assessed
2026-09-07
Grade 1 Decreased appetite — outcome: RECOVERED/RESOLVED; onset 2023-03-03 (study day 38); relationship: not assessed
moderate
assessed
2026-08-08
Grade 2 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2023-02-01 (study day 8); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.